DK131885A - Spiro((imidazolidin, oxazolodin eller thiazolidin)-4,1'-(inden eller 1',2'-dihydronaphthalen))-2,5-dion-forbindelser og farmaceutiske praeparat til behandling af diabetiske komplikationer - Google Patents
Spiro((imidazolidin, oxazolodin eller thiazolidin)-4,1'-(inden eller 1',2'-dihydronaphthalen))-2,5-dion-forbindelser og farmaceutiske praeparat til behandling af diabetiske komplikationer Download PDFInfo
- Publication number
- DK131885A DK131885A DK131885A DK131885A DK131885A DK 131885 A DK131885 A DK 131885A DK 131885 A DK131885 A DK 131885A DK 131885 A DK131885 A DK 131885A DK 131885 A DK131885 A DK 131885A
- Authority
- DK
- Denmark
- Prior art keywords
- oxazolodine
- dihydronaphthalen
- thiazolidine
- imidazolidine
- spiro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59301284A | 1984-03-23 | 1984-03-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK131885D0 DK131885D0 (da) | 1985-03-22 |
| DK131885A true DK131885A (da) | 1985-09-24 |
Family
ID=24372993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK131885A DK131885A (da) | 1984-03-23 | 1985-03-22 | Spiro((imidazolidin, oxazolodin eller thiazolidin)-4,1'-(inden eller 1',2'-dihydronaphthalen))-2,5-dion-forbindelser og farmaceutiske praeparat til behandling af diabetiske komplikationer |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0159143B1 (de) |
| JP (1) | JPS60209572A (de) |
| KR (1) | KR850006188A (de) |
| AU (1) | AU563668B2 (de) |
| CA (1) | CA1244443A (de) |
| DE (1) | DE3561198D1 (de) |
| DK (1) | DK131885A (de) |
| ES (1) | ES8606295A1 (de) |
| FI (1) | FI851170L (de) |
| GR (1) | GR850704B (de) |
| HU (1) | HU195783B (de) |
| IL (1) | IL74667A (de) |
| PH (1) | PH23921A (de) |
| PL (1) | PL145198B1 (de) |
| PT (1) | PT80145B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| EP1605936B1 (de) | 2003-03-14 | 2011-07-20 | Merck Sharp & Dohme Corp. | Aryl-spirohydantoin-cgrp-rezeptor-antagonisten |
| WO2006031676A2 (en) * | 2004-09-13 | 2006-03-23 | Merck & Co., Inc. | Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| US8071770B2 (en) | 2005-11-18 | 2011-12-06 | Merck Sharp & Dohme Corp. | Spirohydantoin aryl CGRP receptor antagonists |
| CN111732545B (zh) * | 2020-06-08 | 2023-03-10 | 华侨大学 | 一种2,3-二氢螺[咪唑-4,1′-茚]类化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| ES8400116A1 (es) * | 1981-10-13 | 1983-10-16 | Pfizer | "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona". |
| ZA832679B (en) * | 1982-05-07 | 1983-12-28 | Ici Plc | Indoline derivatives |
| US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
-
1985
- 1985-03-15 EP EP85301809A patent/EP0159143B1/de not_active Expired
- 1985-03-15 DE DE8585301809T patent/DE3561198D1/de not_active Expired
- 1985-03-19 PH PH32003A patent/PH23921A/en unknown
- 1985-03-20 GR GR850704A patent/GR850704B/el unknown
- 1985-03-20 IL IL74667A patent/IL74667A/xx unknown
- 1985-03-21 KR KR1019850001848A patent/KR850006188A/ko not_active Application Discontinuation
- 1985-03-21 PL PL1985252487A patent/PL145198B1/pl unknown
- 1985-03-21 PT PT80145A patent/PT80145B/pt unknown
- 1985-03-21 CA CA000477079A patent/CA1244443A/en not_active Expired
- 1985-03-21 ES ES541450A patent/ES8606295A1/es not_active Expired
- 1985-03-22 AU AU40251/85A patent/AU563668B2/en not_active Ceased
- 1985-03-22 JP JP60057640A patent/JPS60209572A/ja active Pending
- 1985-03-22 HU HU851108A patent/HU195783B/hu not_active IP Right Cessation
- 1985-03-22 DK DK131885A patent/DK131885A/da not_active Application Discontinuation
- 1985-03-22 FI FI851170A patent/FI851170L/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT80145B (en) | 1987-03-23 |
| CA1244443A (en) | 1988-11-08 |
| DE3561198D1 (en) | 1988-01-28 |
| ES8606295A1 (es) | 1986-04-16 |
| AU4025185A (en) | 1985-09-26 |
| PL145198B1 (en) | 1988-08-31 |
| FI851170A0 (fi) | 1985-03-22 |
| ES541450A0 (es) | 1986-04-16 |
| KR850006188A (ko) | 1985-10-02 |
| HU195783B (en) | 1988-07-28 |
| EP0159143A1 (de) | 1985-10-23 |
| JPS60209572A (ja) | 1985-10-22 |
| DK131885D0 (da) | 1985-03-22 |
| AU563668B2 (en) | 1987-07-16 |
| PH23921A (en) | 1990-01-23 |
| EP0159143B1 (de) | 1987-12-16 |
| FI851170L (fi) | 1985-09-24 |
| HUT37603A (en) | 1986-01-23 |
| IL74667A0 (en) | 1985-06-30 |
| IL74667A (en) | 1988-12-30 |
| PT80145A (en) | 1985-04-01 |
| GR850704B (de) | 1985-07-19 |
| PL252487A1 (en) | 1985-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK165730C (da) | Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling | |
| DK315484D0 (da) | Farmaceutisk praeparat, specielt til behandling af diabetes og fedme | |
| DK106989A (da) | Isoindolinonderivat, fremgangsmaade til fremstilling af dette, og laegemiddel indeholdende dette | |
| DK592685D0 (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK127588A (da) | Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser | |
| DK218985D0 (da) | Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem ogfremgangsmaade til fremstilling af dem | |
| DK131885A (da) | Spiro((imidazolidin, oxazolodin eller thiazolidin)-4,1'-(inden eller 1',2'-dihydronaphthalen))-2,5-dion-forbindelser og farmaceutiske praeparat til behandling af diabetiske komplikationer | |
| DK102990A (da) | Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| DK549087A (da) | Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme | |
| DK163128C (da) | Pyrimidinnucleosider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende pyrimidinnucleosiderne og anvendelse af pyrimidinnucleosiderne | |
| DK488385A (da) | N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK289585A (da) | Arylderivater af heterobicycliske forbindelser, deres farmaceutiske anvendelse og deres fremstilling | |
| DK635988A (da) | 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater | |
| DK187989A (da) | Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser | |
| DK527685D0 (da) | 5-(omega-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno-(3,2-c)-pyridinderivater, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser | |
| DK69387D0 (da) | Cyanoderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne | |
| NO845245L (no) | Etoksylert lignittsammensetning og fremgangsmaate for dens fremstilling. | |
| DK93385D0 (da) | 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser | |
| DK185589D0 (da) | 5-oe2-oen-(2-amino-2-oxo-ethyl)methylaminoaa-ethylaa-3-hydroxy-2(4-methoxyphenyl)-2,3-dihydro-5h-benzothiazepin-1,5-on-4, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser | |
| DK122185D0 (da) | Fremgangsmaader, forbindelser og midler til behandling af protozo-infektioner | |
| DK159319C (da) | 5-(1-cyano-1-alkyl-n-methyl-n-methoxy-phenethyl)-alkyl-amino-2,2,8-trimethyl-4h-dioxino-(4,5-c)-pyridin-derivater, og laegemiddel indeholdende saadanne forbindelser | |
| DK271085D0 (da) | N-benzoyl-n'-pyrimidinyloxyphenylurinstofforbindelser og fremgangsmaade til fremstilling af samme | |
| DK525187D0 (da) | Imidazooe4,5-baapyridinon-2-derivater, fremgangsmaade til fremstilling af og laegemidler indeholdende saadanne derivater | |
| DK343988A (da) | Praeparater med kontrolleret afgivelseshastighed af nulte orden, og fremgangsmaade til fremstilling af saasanne praeparater | |
| DK365087A (da) | 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |